162 related articles for article (PubMed ID: 15915577)
1. Should a clinical trial coordinator blow the whistle?
Brody H
Med Ethics (Burlingt Mass); 2004; 11(1):3, 11. PubMed ID: 15915577
[No Abstract] [Full Text] [Related]
2. Research in the place where you work--some ethical issues.
Butler J
Bull Med Ethics; 2003 Feb; (185):21-2. PubMed ID: 14983853
[No Abstract] [Full Text] [Related]
3. To study, perchance to treat.
Trachtman H
Am J Bioeth; 2009 Feb; 9(2):11-2. PubMed ID: 19180382
[No Abstract] [Full Text] [Related]
4. Randomization can be risky.
Lott J
Am J Bioeth; 2009 Feb; 9(2):17-8. PubMed ID: 19180386
[No Abstract] [Full Text] [Related]
5. Understanding randomization: helpful strategies.
Brody H; Childress AM
Am J Bioeth; 2009 Feb; 9(2):14-5. PubMed ID: 19180384
[No Abstract] [Full Text] [Related]
6. Equipoise trumps randomization.
Fox MD; Hellman CM; Jelley MR
Am J Bioeth; 2009 Feb; 9(2):13-4. PubMed ID: 19180383
[No Abstract] [Full Text] [Related]
7. The dirty little truth: we want them to understand, but not really..
Morreim H
Am J Bioeth; 2009 Feb; 9(2):9-11. PubMed ID: 19180381
[No Abstract] [Full Text] [Related]
8. Randomization and the transactional framework for informed consent.
Reynolds D; Fleming DA
Am J Bioeth; 2009 Feb; 9(2):16-7. PubMed ID: 19180385
[No Abstract] [Full Text] [Related]
9. The "research misconception" and the SUPPORT trial: toward evidence-based consensus.
Wilkinson DJ; Gerrand N; Cruz M; Tarnow-Mordi W
Am J Bioeth; 2013; 13(12):48-50. PubMed ID: 24256540
[No Abstract] [Full Text] [Related]
10. Randomization should be disclosed to potential research subjects.
Binik A; Sheehan M
Am J Bioeth; 2013; 13(12):35-7. PubMed ID: 24256533
[No Abstract] [Full Text] [Related]
11. Equipoise may be in the eye of the beholder.
Moyer A; Floyd AH
Am J Bioeth; 2009 Feb; 9(2):21-2. PubMed ID: 19180388
[No Abstract] [Full Text] [Related]
12. What are reasonably foreseeable risks?
Resnik DB
Am J Bioeth; 2013; 13(12):29-30. PubMed ID: 24256530
[No Abstract] [Full Text] [Related]
13. Ensuring transparency: presenting the trade-offs between the research treatment options.
Schreiner MS
Am J Bioeth; 2013; 13(12):50-2. PubMed ID: 24256541
[No Abstract] [Full Text] [Related]
14. Risk, respect for persons, and informed consent in comparative effectiveness research.
Spellecy R; Leuthner S; Farrell M
Am J Bioeth; 2013; 13(12):46-8. PubMed ID: 24256539
[No Abstract] [Full Text] [Related]
15. The weird divergence of ethics and regulation with regard to informed consent.
Lantos JD
Am J Bioeth; 2013; 13(12):31-3. PubMed ID: 24256531
[No Abstract] [Full Text] [Related]
16. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
Howick J
Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192
[TBL] [Abstract][Full Text] [Related]
17. What should be disclosed to research participants?
Wendler D
Am J Bioeth; 2013; 13(12):3-8. PubMed ID: 24256522
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility and full disclosure of genetic results to research participants.
Sharp RR; Foster MW
Am J Bioeth; 2006; 6(6):42-4; author reply W10-2. PubMed ID: 17085408
[No Abstract] [Full Text] [Related]
19. Bounty-hunting and finder's fees.
Christensen JA; Orlowski JP
IRB; 2005; 27(3):16-9. PubMed ID: 16021797
[No Abstract] [Full Text] [Related]
20. No sex please in sexuality research.
Haire B
Am J Bioeth; 2010 Jul; 10(7):43-4. PubMed ID: 20582830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
